Revolutionary Pulsed Field Ablation Treatment for Atrial Fibrillation Making Waves in Medical Field
Discover the revolutionary treatment approach for atrial fibrillation (AF) with pulsed field ablation (PFA). This cutting-edge technology is set to outshine traditional methods, offering enhanced safety and efficacy in addressing heart rhythm disorders. With recent FDA approvals and market milestones, PFA is poised to transform AF treatment in the US, promising a brighter future in cardiac care.
Treating Gum Disease May Lower Risk of Irregular Heart Rate
Treating gum disease may lower the risk of atrial fibrillation reoccurring, according to a new study. Researchers found that those whose gum disease was treated after ablation were 61% less likely to experience a reoccurrence. The study measured elevated levels of inflammatory proteins in the blood of participants with severe gum disease, and higher levels of antibodies for gum disease-related bacteria were linked to greater atrial fibrillation reoccurrence. The team encourages people with atrial fibrillation to seek treatment for gum disease if necessary, emphasizing preventive measures such as brushing with fluoride toothpaste at least twice a day, daily flossing or using interdental sticks, and regular dental check-ups.
Study Links Sweetened Beverages to Increased Risk of Irregular Heart Rhythms
Study published in Circulation: Arrhythmia and Electrophysiology links sweetened beverage consumption to increased risk of irregular heart rhythms. Consuming two liters or more per week of artificially sweetened drinks associated with 20% higher risk of atrial fibrillation. Conversely, consuming one liter or less of unsweetened juice per week linked to 8% lower risk. Observational study suggests potential health risks associated with sweetened beverages, shedding light on the impact on heart health and the need for further research.
Cleveland Clinic Pioneers New Tissue-Sparing Ablation Procedure for Atrial Fibrillation
Cleveland Clinic has made headlines for being among the first hospitals to perform a new tissue-sparing ablation procedure known as pulsed field ablation (PFA). This innovative technology offers a safer and more effective alternative for patients with symptomatic atrial fibrillation (Afib), providing hope for improved outcomes and quality of life for individuals living with Afib.
Study Shows Apixaban Lowers Risk of Stroke in Patients with Subclinical Atrial Fibrillation
In a recent study published in the field of Cardiology, it has been found that apixaban, a type of oral anticoagulant, significantly lowers the risk of stroke or systemic embolism in patients with subclinical atrial fibrillation. This finding is significant…